Page last updated: 2024-11-04

sulpiride and Psychoses

sulpiride has been researched along with Psychoses in 95 studies

Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.

Research Excerpts

ExcerptRelevanceReference
"Both amisulpride and olanzapine produce sustained improvement in certain measures of neuropsychological performance in patients with schizophrenia; a significant improvement in score on the AVLT was observed only with amisulpride."9.12Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia. ( Balasubramaniam, K; Choudhary, PC; Joyce, E; Mortimer, AM; Saleem, PT, 2007)
"In a material of 71 patients admitted because of acute or chronic psychoses, 32 were treated with sulpiride (up to 1,800 mg per day) and 39 with chlorpromazine (up to 675 mg)."9.04Comparison of sulpiride and chlorpromazine in psychoses. A double-blind multicentre study. ( Bratfos, O; Haug, JO, 1979)
"Excessive body weight gain, hyperprolactinemia and low gonadal steroid serum levels are often observed during chronic administration of antipsychotic drugs (AP)."6.69Body weight gain after administration of antipsychotic drugs: correlation with leptin, insulin and reproductive hormones. ( Angeles, F; Baptista, T; de Mendoza, S; Hernández, L; Lacruz, A; Mendoza Guillén, JM; Mendoza, MT; Silvera, R, 2000)
"Sulpiride is a selective D2-receptor antagonist with antipsychotic and antidepressant properties."5.28Sulpiride-induced tardive dystonia. ( Jankovic, J; Miller, LG, 1990)
"The study was designed as a 6-week, two-center, fixed-dose, comparison study of 400 mg/day of amisulpride versus 300 mg/day of moclobemide as an adjunctive treatment in 53 schizophrenia and schizoaffective disorder patients (diagnosed according to DSM-IV) suffering from CIS."5.15Amisulpride versus moclobemide in treatment of clozapine-induced hypersalivation. ( Bergman, J; Kreinin, A; Lerner, V; Libov, I; Miodownik, C; Shestakova, D; Sokolik, S, 2011)
"To compare the effects of haloperidol, amisulpride, olanzapine, quetiapine, and ziprasidone on hostility in first-episode schizophrenia, schizoaffective disorder, or schizophreniform disorder."5.15Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST). ( Bitter, I; Czobor, P; Derks, EM; Fleischhacker, WW; Kahn, RS; Libiger, J; Volavka, J, 2011)
"Both amisulpride and olanzapine produce sustained improvement in certain measures of neuropsychological performance in patients with schizophrenia; a significant improvement in score on the AVLT was observed only with amisulpride."5.12Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia. ( Balasubramaniam, K; Choudhary, PC; Joyce, E; Mortimer, AM; Saleem, PT, 2007)
"In a material of 71 patients admitted because of acute or chronic psychoses, 32 were treated with sulpiride (up to 1,800 mg per day) and 39 with chlorpromazine (up to 675 mg)."5.04Comparison of sulpiride and chlorpromazine in psychoses. A double-blind multicentre study. ( Bratfos, O; Haug, JO, 1979)
" The authors present a case of amisulpiride-induced catatonia, further evaluation suggested neuroleptic malignant syndrome (NMS) and showed the occurrence of temporal lobe epilepsy (TLE) and underlying brain pathology with marked frontoparietal atrophy and periventricular white matter hyperintensities."3.75Catatonia, neuroleptics and brain damage--a case report. ( Chandran, M; El-Shazly, M, 2009)
"During clinical experience with the "atypical" neuroleptic drugs clozapine, risperidone, and zotepine, some patients have shown a marked weight gain."3.70Weight gain: side effect of atypical neuroleptics? ( Müssigbrodt, HE; Wetterling, T, 1999)
"Psychotic depression is classified as a clinical subtype of major depressive disorder."2.73Combination therapy with amisulpride and antidepressants: clinical observations in case series of elderly patients with psychotic depression. ( Papadimitriou, GN; Politis, AM; Psarros, C; Soldatos, CR; Theleritis, CG, 2008)
"Excessive body weight gain, hyperprolactinemia and low gonadal steroid serum levels are often observed during chronic administration of antipsychotic drugs (AP)."2.69Body weight gain after administration of antipsychotic drugs: correlation with leptin, insulin and reproductive hormones. ( Angeles, F; Baptista, T; de Mendoza, S; Hernández, L; Lacruz, A; Mendoza Guillén, JM; Mendoza, MT; Silvera, R, 2000)
"Sulpiride was superior to CPZ in reducing the autistic symptoms."2.66Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients--relationship to drug concentrations. ( Alfredsson, G; Härnryd, C; Wiesel, FA, 1985)
"22 patients (8 manic-depressive psychoses and 14 schizophrenias) were given sultopride as the sole therapy, in a daily dose of 4 vials."2.65[Longterm psychosis and sultopride]. ( Morel, D, 1983)
"Treatment with Lamotrigine and Amisulpiride achieved an excellent response, and she has remained symptom free for 7 months."2.48Temporal lobe epilepsy masquerading as psychosis--a case report and literature review. ( Hamelijnck, J; Needham, E, 2012)
"Even though akathisia is less prevalent with SGAs than with the first-generation drugs, it remains clinically important and all clinicians should be conversant with its recognition and management."2.45Akathisia and second-generation antipsychotic drugs. ( Kumar, R; Sachdev, PS, 2009)
" Amisulpride shows linear pharmacokinetics, a bioavailability of 48%, low protein binding (17%) and an elimination half-life of approximately 12 h."2.41A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers. ( Bergougnan, L; Bianchetti, G; Canal, M; Patat, A; Rosenzweig, P; Zieleniuk, I, 2002)
"Schizoaffective disorder is listed in the category "schizophrenia and other psychotic disorders"."2.41[Schizoaffective disorder: clinical symptoms and present-day approach to treatment]. ( Danileviciūte, V, 2002)
"Risperidone appears to be an effective therapy, but several authors report cases of TD during treatment."2.41Tardive dyskinesias and antipsychotics: a review. ( Bayle, FJ; Chereau, I; Lancon, C; Llorca, PM, 2002)
"Antipsychotic drugs are effective in psychoses, whatever the aetiology of the disorder."2.40Recent developments in the management of psychosis. ( Hoes, MJ, 1998)
" Model predictions were used to simulate dose-response and dose-EPS."1.46A Population Approach to Guide Amisulpride Dose Adjustments in Older Patients With Alzheimer's Disease. ( Bertrand, J; Brownings, S; D'Antonio, F; Dunn, JT; Greaves, S; Howard, R; Kessler, R; Marsden, P; McLachlan, E; Nair, A; Reeves, S; Smith, A; Taylor, D; Uchida, H, 2017)
"A shorter duration of untreated psychosis has been associated with better prognosis in schizophrenia."1.39Mismatch negativity and cognitive performance for the prediction of psychosis in subjects with at-risk mental state. ( Higuchi, Y; Kawasaki, Y; Miyanishi, T; Seo, T; Sumiyoshi, T; Suzuki, M, 2013)
"Acute psychosis is diagnosed by clearly defined operational criteria embedded into international classification systems."1.36Gender, psychosis and psychotropic drugs: differences and similarities. ( Groleger, U; Novak-Grubic, V, 2010)
" Besides this, the chronic administration of neuroleptic drugs may induce a hypersensitivity to dopamine agonists."1.35Aripiprazole in combination with other antipsychotic drugs may worsen psychosis. ( Adan-Manes, J; Garcia-Parajua, P, 2009)
" No significant correlation was detected between prolactin levels and either amisulpride dosage or duration of administration."1.34Amisulpride-induced hyperprolactinemia is reversible following discontinuation. ( Liappas, J; Mourikis, I; Paparrigopoulos, T; Soldatos, C; Tzavellas, E, 2007)
" However, no correlation between prolactin levels and dosage could be found."1.32[Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics]. ( Fric, M; Laux, G, 2003)
"Ten adolescent cases are presented with regard to the efficacy, side effects and dosage of amisulpride."1.31[Initial experiences with amisulpride, an in Germany novel, atypical neuroleptic drug in treatment of adolescents with psychiatric disorders]. ( Göpel, C; Marcus, A, 2001)
"Sulpiride is a selective D2-receptor antagonist with antipsychotic and antidepressant properties."1.28Sulpiride-induced tardive dystonia. ( Jankovic, J; Miller, LG, 1990)
"Treatment with sulpiride was associated with marked reductions in psychotic morbidity."1.26Effect of sulpiride on monoaminergic mechanisms in psychotic women. ( Bjerkenstedt, L; Härnryd, C; Sedval, G, 1979)

Research

Studies (95)

TimeframeStudies, this research(%)All Research%
pre-199023 (24.21)18.7374
1990's9 (9.47)18.2507
2000's40 (42.11)29.6817
2010's23 (24.21)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reeves, S3
McLachlan, E2
Bertrand, J2
D'Antonio, F2
Brownings, S3
Nair, A2
Greaves, S3
Smith, A2
Taylor, D3
Dunn, J1
Marsden, P3
Kessler, R3
Howard, R3
Dunn, JT2
Uchida, H1
Barrimi, M1
El Ghazouani, F1
Zaimi, O1
Oneib, B1
Naguy, A1
AlHumoud, A1
Bernacer, J1
Corlett, PR1
Ramachandra, P1
McFarlane, B1
Turner, DC1
Clark, L1
Robbins, TW1
Fletcher, PC1
Murray, GK1
Clark-Papasavas, C1
Mogg, A1
Gomes, R1
Liu, K1
Nwosu, B1
Joemon, J1
Cleij, M1
Seeman, P1
Leucht, S2
Winter-van Rossum, I1
Heres, S1
Arango, C1
Fleischhacker, WW3
Glenthøj, B2
Leboyer, M1
Leweke, FM1
Lewis, S1
McGuire, P1
Meyer-Lindenberg, A1
Rujescu, D1
Kapur, S2
Kahn, RS3
Sommer, IE2
Vinkers, CH1
Ebdrup, BH1
Raghava, JM1
Nielsen, MØ1
Rostrup, E1
Bas, A1
Gultekin, G1
Incir, S1
Bas, TO1
Emul, M1
Duran, A1
Chandran, M1
El-Shazly, M1
Müller, MJ1
Eich, FX1
Regenbogen, B1
Sachse, J1
Härtter, S1
Hiemke, C1
Meisenzahl, EM1
Schmitt, G1
Gründer, G1
Dresel, S1
Frodl, T1
la Fougère, C1
Scheuerecker, J1
Schwarz, M1
Boerner, R1
Stauss, J1
Hahn, K1
Möller, HJ2
Adan-Manes, J1
Garcia-Parajua, P1
Varol Tas, F1
Guvenir, T1
Kumar, R1
Sachdev, PS1
Crespo-Facorro, B1
Rodríguez-Sánchez, JM1
Pérez-Iglesias, R1
Mata, I1
Ayesa, R1
Ramirez-Bonilla, M1
Martínez-Garcia, O1
Vázquez-Barquero, JL1
Sparshatt, A1
Patel, MX1
Rizos, E1
Douzenis, A1
Gournellis, R1
Christodoulou, C1
Lykouras, LP1
Bakhla, AK1
Goyal, N1
Nizamie, SH1
Höfer, P1
Friedrich, F1
Vyssoki, B1
Spindelegger, C1
Schmook, M1
Barnas, C1
Lesch, OM1
Walter, H1
Groleger, U1
Novak-Grubic, V1
Chen, JH1
Tzeng, NS1
Kreinin, A1
Miodownik, C1
Sokolik, S1
Shestakova, D1
Libov, I1
Bergman, J1
Lerner, V1
Moons, T1
Claes, S1
Martens, GJ1
Peuskens, J1
Van Loo, KM1
Van Schijndel, JE1
De Hert, M1
van Winkel, R1
Volavka, J1
Czobor, P1
Derks, EM1
Bitter, I2
Libiger, J2
Needham, E1
Hamelijnck, J1
Zedkova, I1
Dudova, I1
Urbanek, T1
Hrdlicka, M1
Kost, NV1
Meshavkin, VK1
Batishcheva, EIu1
Sokolov, OIu1
Andreeva, LA1
Miasoedov, NF1
Galderisi, S1
Mucci, A1
Bucci, P1
Danilov, DS1
Higuchi, Y1
Sumiyoshi, T1
Seo, T1
Miyanishi, T1
Kawasaki, Y1
Suzuki, M1
Rosenzweig, P1
Canal, M1
Patat, A1
Bergougnan, L1
Zieleniuk, I1
Bianchetti, G1
Danileviciūte, V1
Fric, M1
Laux, G1
Wagenpfeil, S1
Hamann, J1
Kissling, W1
Zink, M1
Henn, FA1
Thome, J1
Bressan, RA1
Erlandsson, K1
Spencer, EP2
Ell, PJ1
Pilowsky, LS1
Bergemann, N2
Kopitz, J2
Kress, KR2
Frick, A2
Agelink, MW1
Kavuk, I1
Ak, I1
Jagadheesan, K1
Muirhead, D1
Stahl, S1
Freudenreich, O1
Goff, D1
Bliesener, N1
Yokusoglu, H1
Quednow, BB1
Klingmüller, D1
Kühn, KU2
Raja, M1
Azzoni, A1
Taylor, M1
Turner, M1
Watt, L1
Brown, D1
Martin, M1
Fraser, K1
Saft, C1
Andrich, J1
Kraus, PH1
Przuntek, H1
Paparrigopoulos, T1
Liappas, J1
Tzavellas, E1
Mourikis, I1
Soldatos, C1
Lecrubier, Y1
Quintin, P1
Bouhassira, M1
Perrin, E1
Lancrenon, S1
Murphy, BP1
Stuart, AH1
Wade, D1
Cotton, S1
McGorry, PD1
Lim, HK1
Pae, CU1
Lee, C1
Lee, CU1
Bret, MC1
Bret, P1
Pariente, A1
Fourier-Réglat, A1
Mortimer, AM1
Joyce, E1
Balasubramaniam, K1
Choudhary, PC1
Saleem, PT1
Gibbs, AA1
Naudts, KH1
David, AS1
Ruhrmann, S1
Bechdolf, A1
Wagner, M1
Schultze-Lutter, F1
Janssen, B1
Maurer, K1
Häfner, H1
Gaebel, W1
Maier, W1
Klosterkötter, J1
Yalcin, DO1
Goka, E1
Aydemir, MC1
Kisa, C1
Politis, AM1
Papadimitriou, GN1
Theleritis, CG1
Psarros, C1
Soldatos, CR1
Gerlach, J2
Szymonowicz, R1
Morel, D2
Miyachi, Y1
Mizuchi, A1
Hamano, H1
Sarai, K1
Peacock, L1
Hoes, MJ1
Wetterling, T1
Müssigbrodt, HE1
Olie, JP1
Ghaoui, S1
Bayle, FJ2
Baptista, T1
Lacruz, A1
de Mendoza, S1
Mendoza Guillén, JM1
Silvera, R1
Angeles, F1
Mendoza, MT1
Hernández, L1
Komarov, FI1
Rapoport, SI1
Ivanov, SV1
Kharaian, LV1
Kolesnikov, DB1
Kurikov, AV1
Jatzko, A1
Ries, S1
Schreiner, A1
Braus, DF1
Göpel, C1
Marcus, A1
Llorca, PM1
Chereau, I1
Lancon, C1
Scotto, JC2
Bjerkenstedt, L1
Härnryd, C2
Sedval, G1
Bratfos, O1
Haug, JO1
Coulon, P1
Richou, H1
Hug, R1
Caroli, F1
Littre-Poirier, MF1
Ginestet, D1
Deniker, P1
Waldmeier, PC1
Maître, L1
Pelc, I1
Abe, K1
de Francisco, CP1
Dufour, H1
Castelli, J1
Luccioni, H1
Sutter, JM1
Maurel, H1
Pujol, B1
Gabellini, AS1
Pezzoli, A1
De Massis, P1
Sacquegna, T1
Stárková, L1
Wiedermann, J1
Miller, LG1
Jankovic, J1
Svestka, J1
Rysánek, R1
Náhunek, K1
Cesková, E1
Molcan, J1
Forgácová, L1
Huncík, P1
Haumonte, MT1
Hoffmann, E1
Koriche, A1
Vallindra, C1
Gaume, JY1
Leser, J1
Alfredsson, G1
Wiesel, FA1
Soni, SD1
Freeman, HL1
Mercier, M1
Halpern, B2
Sircovich, O2
Winnik, HZ2
Bente, D1
Koeller, DM1
Koufen, H1
Pietzcker, A1
Schulte, PW1

Clinical Trials (4)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparison of Benzamide Derivates (Amisulpride, Moclobemide and Tiapride) as Treatment of Clozapine-induced Hypersalivation: Pilot Double Phase Study: Open and Double-blind[NCT00534573]Phase 354 participants (Actual)Interventional2008-11-30Completed
Effectiveness of the RemedRugby Program, a Program of Ecological Cognitive Remediation of Social Cognition Disorders in Schizophrenia[NCT03775564]60 participants (Actual)Interventional2014-11-30Completed
Therapy With Bromocriptine in Patients With Symptomatic Risperidone-Induced Hyperprolactinemia[NCT00315081]Phase 320 participants Interventional2006-05-31Not yet recruiting
Dopamine D2/3- and μ-opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity in Healthy Volunteers[NCT02557984]121 participants (Actual)Interventional2014-02-28Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

12 reviews available for sulpiride and Psychoses

ArticleYear
The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychotics.
    Schizophrenia bulletin, 2015, Volume: 41, Issue:3

    Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Clinical Trials

2015
[Amisulpride: a treatment option for psychotic disorders soon to be available in the Netherlands].
    Tijdschrift voor psychiatrie, 2015, Volume: 57, Issue:11

    Topics: Antipsychotic Agents; Humans; Netherlands; Psychotic Disorders; Sulpiride

2015
Akathisia and second-generation antipsychotic drugs.
    Current opinion in psychiatry, 2009, Volume: 22, Issue:3

    Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Hum

2009
Amisulpride - dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring.
    Acta psychiatrica Scandinavica, 2009, Volume: 120, Issue:6

    Topics: Amisulpride; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Drug Monitoring

2009
Temporal lobe epilepsy masquerading as psychosis--a case report and literature review.
    Neurocase, 2012, Volume: 18, Issue:5

    Topics: Adult; Amisulpride; Anticonvulsants; Antipsychotic Agents; Diagnosis, Differential; Epilepsy, Tempor

2012
[Possibilities in using sulpiride in the treatment of psychotic disorders].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2012, Volume: 112, Issue:6

    Topics: Antipsychotic Agents; Humans; Psychotic Disorders; Sulpiride

2012
A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers.
    Human psychopharmacology, 2002, Volume: 17, Issue:1

    Topics: Amisulpride; Antipsychotic Agents; Clinical Trials as Topic; Dopamine; Electroencephalography; Human

2002
[Schizoaffective disorder: clinical symptoms and present-day approach to treatment].
    Medicina (Kaunas, Lithuania), 2002, Volume: 38, Issue:11

    Topics: Adolescent; Amisulpride; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antimanic

2002
New antipsychotics: the present status.
    International clinical psychopharmacology, 1995, Volume: 10 Suppl 3

    Topics: Antipsychotic Agents; Binding, Competitive; Clozapine; Dopamine Antagonists; Haloperidol; Humans; Ps

1995
Recent developments in the management of psychosis.
    Pharmacy world & science : PWS, 1998, Volume: 20, Issue:3

    Topics: Antipsychotic Agents; Clozapine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Respon

1998
[New antipsychotic agents].
    L'Encephale, 1999, Volume: 25 Spec No 3

    Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Imidazole

1999
Tardive dyskinesias and antipsychotics: a review.
    European psychiatry : the journal of the Association of European Psychiatrists, 2002, Volume: 17, Issue:3

    Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dyskinesia, Drug-Induced; Humans; Ola

2002

Trials

30 trials available for sulpiride and Psychoses

ArticleYear
Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer's disease.
    Brain : a journal of neurology, 2017, 04-01, Volume: 140, Issue:4

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amisulpride; Antipsychotic Agents; Benzamides; Dopamine

2017
Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disorder.
    Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:3

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Comorbid

2009
Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study.
    Pharmacopsychiatry, 2008, Volume: 41, Issue:5

    Topics: Adult; Amisulpride; Antipsychotic Agents; Benzamides; Corpus Striatum; Dose-Response Relationship, D

2008
Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
    The Journal of clinical psychiatry, 2009, Apr-21, Volume: 70, Issue:5

    Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Cognition Disorders; Fe

2009
Amisulpride versus moclobemide in treatment of clozapine-induced hypersalivation.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2011, Volume: 12, Issue:8

    Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Clozapine; Cross-Over Studies; Female; Humans; Male;

2011
Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST).
    The Journal of clinical psychiatry, 2011, Volume: 72, Issue:7

    Topics: Adult; Aggression; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Haloperid

2011
Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2013, Volume: 23, Issue:3

    Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Dibenzot

2013
Amisulpride is an "atypical" antipsychotic associated with low weight gain.
    Psychopharmacology, 2004, Volume: 173, Issue:1-2

    Topics: Amisulpride; Antipsychotic Agents; Databases as Topic; Dose-Response Relationship, Drug; Humans; Mal

2004
Plasma amisulpride levels in schizophrenia or schizoaffective disorder.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2004, Volume: 14, Issue:3

    Topics: Adolescent; Adult; Age Factors; Amisulpride; Antipsychotic Agents; Biomimetics; Chromatography, High

2004
Clozapine with amisulpride for refractory schizophrenia.
    The American journal of psychiatry, 2004, Volume: 161, Issue:5

    Topics: Adult; Amisulpride; Antipsychotic Agents; Brief Psychiatric Rating Scale; Clozapine; Drug Therapy, C

2004
Usefulness of bromocriptine in the treatment of amisulpride-induced hyperprolactinemia: a case report.
    Pharmacopsychiatry, 2004, Volume: 37, Issue:4

    Topics: Adult; Amisulpride; Antipsychotic Agents; Bromocriptine; Estradiol; Female; Follicle Stimulating Hor

2004
Amisulpride has no effect on plasma clozapine concentrations.
    Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:5

    Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Drug Combinations; Drug Interactions; Female; H

2005
The treatment of negative symptoms and deficit states of chronic schizophrenia: olanzapine compared to amisulpride and placebo in a 6-month double-blind controlled clinical trial.
    Acta psychiatrica Scandinavica, 2006, Volume: 114, Issue:5

    Topics: Adult; Affect; Amisulpride; Antipsychotic Agents; Attention; Basal Ganglia Diseases; Benzodiazepines

2006
Efficacy of amisulpride in treating primary negative symptoms in first-episode psychosis: a pilot study.
    Human psychopharmacology, 2006, Volume: 21, Issue:8

    Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Female; Humans; Male; Neuropsychological Tests

2006
Amisulpride versus risperidone treatment for behavioral and psychological symptoms in patients with dementia of the Alzheimer type: a randomized, open, prospective study.
    Neuropsychobiology, 2006, Volume: 54, Issue:4

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amisulpride; Antipsychotic Agents; Behavioral Symptoms;

2006
Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia.
    Human psychopharmacology, 2007, Volume: 22, Issue:7

    Topics: Acute Disease; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Dose-

2007
The role of dopamine in attentional and memory biases for emotional information.
    The American journal of psychiatry, 2007, Volume: 164, Issue:10

    Topics: Adolescent; Adult; Amisulpride; Attention; Dopamine; Dopamine Antagonists; Emotions; Humans; Male; M

2007
Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis.
    The British journal of psychiatry. Supplement, 2007, Volume: 51

    Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Combined Modality Therapy; Drug Administration

2007
Combination therapy with amisulpride and antidepressants: clinical observations in case series of elderly patients with psychotic depression.
    Progress in neuro-psychopharmacology & biological psychiatry, 2008, Jul-01, Volume: 32, Issue:5

    Topics: Aged; Aged, 80 and over; Amisulpride; Antidepressive Agents; Antipsychotic Agents; Depression; Drug

2008
[Longterm psychosis and sultopride].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1983, Sep-22, Volume: 59, Issue:33

    Topics: Adult; Amisulpride; Chronic Disease; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Ps

1983
[Early infantile psychoses and sultopride].
    Neuropsychiatrie de l'enfance et de l'adolescence, 1982, Volume: 30, Issue:6

    Topics: Adult; Amisulpride; Clinical Trials as Topic; Humans; Male; Psychotic Disorders; Psychotropic Drugs;

1982
Body weight gain after administration of antipsychotic drugs: correlation with leptin, insulin and reproductive hormones.
    Pharmacopsychiatry, 2000, Volume: 33, Issue:3

    Topics: Adult; Antipsychotic Agents; Estradiol; Female; Follicle Stimulating Hormone; Hormones; Humans; Insu

2000
[Sulpiride treatment of irritable colon syndrome].
    Klinicheskaia meditsina, 2000, Volume: 78, Issue:7

    Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Cholagogues and Choleretics; Colonic Di

2000
Comparison of sulpiride and chlorpromazine in psychoses. A double-blind multicentre study.
    Acta psychiatrica Scandinavica, 1979, Volume: 60, Issue:1

    Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Humans; Middl

1979
[Trial of interruption of antiparkinson drugs in long term treatments with neuroleptics].
    L'Encephale, 1975, Volume: 1, Issue:1

    Topics: Adult; Antiparkinson Agents; Basal Ganglia Diseases; Chlorpromazine; Clinical Trials as Topic; Fluph

1975
[A new substituted benzamide with neuroleptic effects: lin 14 18 or sultopride].
    L'Encephale, 1975, Volume: 1, Issue:1

    Topics: Adult; Aged; Benzamides; Clinical Trials as Topic; Delusions; Drug Evaluation; Humans; Male; Middle

1975
[Situation of sultopride among present-day neuroleptics].
    L'Encephale, 1975, Volume: 1, Issue:1

    Topics: Anxiety; Asthenia; Basal Ganglia Diseases; Benzamides; Bipolar Disorder; Clinical Trials as Topic; D

1975
[Results of treatment of schizophrenic and schizoaffective patients with sulpiride (Eglonyl Alkaloid) in comparison with perphenazine (Perfenazin Spofa)].
    Ceskoslovenska psychiatrie, 1990, Volume: 86, Issue:3

    Topics: Adolescent; Adult; Humans; Middle Aged; Perphenazine; Psychotic Disorders; Schizophrenia; Sulpiride

1990
Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients--relationship to drug concentrations.
    Psychopharmacology, 1985, Volume: 85, Issue:1

    Topics: Adolescent; Adult; Autistic Disorder; Behavior; Chlorpromazine; Clinical Trials as Topic; Double-Bli

1985
[Clinico-statistical study of the effects of sulpiride, a new psychopharmacologic agent].
    Arzneimittel-Forschung, 1974, Volume: 24, Issue:1

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Clinical Trials as Topic; Computers; Female; Humans;

1974

Other Studies

53 other studies available for sulpiride and Psychoses

ArticleYear
A Population Approach to Guide Amisulpride Dose Adjustments in Older Patients With Alzheimer's Disease.
    The Journal of clinical psychiatry, 2017, Volume: 78, Issue:7

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amisulpride; Basal Ganglia Diseases; Brain; Delusions; D

2017
[Neuroleptic malignant syndrome under amisulpride in a patient during a second acute psychotic episode].
    Presse medicale (Paris, France : 1983), 2018, Volume: 47, Issue:2

    Topics: Acute Disease; Adult; Amisulpride; Antipsychotic Agents; Female; Humans; Neuroleptic Malignant Syndr

2018
An octogenarian with Parkinson's disease psychosis that has responded favourably to low-dose sulpiride with facilitated motoric agility.
    Asian journal of psychiatry, 2019, Volume: 43

    Topics: Aged, 80 and over; Antipsychotic Agents; Humans; Male; Parkinson Disease; Psychotic Disorders; Sulpi

2019
Methamphetamine-induced disruption of frontostriatal reward learning signals: relation to psychotic symptoms.
    The American journal of psychiatry, 2013, Volume: 170, Issue:11

    Topics: Adult; Amisulpride; Antipsychotic Agents; Basal Ganglia; Central Nervous System Stimulants; Corpus S

2013
Towards a therapeutic window of D2/3 occupancy for treatment of psychosis in Alzheimer's disease, with [18F]fallypride positron emission tomography.
    International journal of geriatric psychiatry, 2014, Volume: 29, Issue:10

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amisulpride; Antipsychotic Agents; Benzamides; Brain Map

2014
Therapeutic occupation of dopamine D2 antipsychotic receptors in Alzheimer's disease.
    International journal of geriatric psychiatry, 2014, Volume: 29, Issue:10

    Topics: Alzheimer Disease; Amisulpride; Antipsychotic Agents; Benzamides; Brain Mapping; Female; Humans; Mal

2014
Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade.
    Journal of psychiatry & neuroscience : JPN, 2016, Volume: 41, Issue:2

    Topics: Acute Disease; Adult; Amisulpride; Anisotropy; Antipsychotic Agents; Brain; Diffusion Magnetic Reson

2016
Level of serum thioredoxin and correlation with neurocognitive functions in patients with schizophrenia using clozapine and other atypical antipsychotics.
    Psychiatry research, 2017, Volume: 247

    Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition; Female; Humans; Mal

2017
Catatonia, neuroleptics and brain damage--a case report.
    Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:2

    Topics: Amisulpride; Antipsychotic Agents; Atrophy; Catatonia; Epilepsy, Temporal Lobe; Female; Frontal Lobe

2009
Aripiprazole in combination with other antipsychotic drugs may worsen psychosis.
    Journal of clinical pharmacy and therapeutics, 2009, Volume: 34, Issue:2

    Topics: Amisulpride; Anti-Dyskinesia Agents; Antipsychotic Agents; Aripiprazole; Biperiden; Dopamine; Drug T

2009
Amisulpride treatment of adolescent patients with schizophrenia or schizo-affective disorders.
    European child & adolescent psychiatry, 2009, Volume: 18, Issue:8

    Topics: Adolescent; Amisulpride; Antiparkinson Agents; Antipsychotic Agents; Biperiden; Dose-Response Relati

2009
Tardive dyskinesia in a patient treated with quetiapine.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2009, Volume: 10, Issue:1

    Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Dibenzothiazepines; Dyskine

2009
Amisulpride-induced mania with interictal psychosis.
    Progress in neuro-psychopharmacology & biological psychiatry, 2009, Nov-13, Volume: 33, Issue:8

    Topics: Adolescent; Amisulpride; Antipsychotic Agents; Bipolar Disorder; Humans; Male; Psychotic Disorders;

2009
Hyperprolactinaemia and acute psychosis: prolactinoma or medication-induced phenomenon?
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2010, Volume: 11, Issue:5

    Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Follow-Up Studies; Humans; Hyperprolacti

2010
Gender, psychosis and psychotropic drugs: differences and similarities.
    Psychiatria Danubina, 2010, Volume: 22, Issue:2

    Topics: Acute Disease; Adult; Affect; Amisulpride; Antipsychotic Agents; Benzodiazepines; Brain; Dose-Respon

2010
Successful treatment with amisulpride for poststroke psychosis.
    The Journal of neuropsychiatry and clinical neurosciences, 2010,Summer, Volume: 22, Issue:3

    Topics: Amisulpride; Antipsychotic Agents; Female; Humans; Middle Aged; Psychotic Disorders; Stroke; Sulpiri

2010
Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugs.
    Schizophrenia research, 2011, Volume: 125, Issue:2-3

    Topics: Adult; Age Factors; Alleles; Amisulpride; Anthropometry; Antipsychotic Agents; Aripiprazole; Benzodi

2011
Onset of action of atypical and typical antipsychotics in the treatment of adolescent schizophrenic psychoses.
    Neuro endocrinology letters, 2011, Volume: 32, Issue:5

    Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Female; Haloperido

2011
[Neurotensin-like oligopeptides as potential antipsychotics: effect on dopamine system].
    Eksperimental'naia i klinicheskaia farmakologiia, 2011, Volume: 74, Issue:10

    Topics: Animals; Animals, Outbred Strains; Antipsychotic Agents; Apomorphine; Behavior, Animal; Dopamine; Do

2011
Mismatch negativity and cognitive performance for the prediction of psychosis in subjects with at-risk mental state.
    PloS one, 2013, Volume: 8, Issue:1

    Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Cognition Disorders; Electroencephalography;

2013
[Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics].
    Psychiatrische Praxis, 2003, Volume: 30 Suppl 2

    Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Dibenzothiaze

2003
Combination of amisulpride and olanzapine in treatment-resistant schizophrenic psychoses.
    European psychiatry : the journal of the Association of European Psychiatrists, 2004, Volume: 19, Issue:1

    Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Drug Resistance; Drug Therapy, Combinatio

2004
Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients.
    Psychopharmacology, 2004, Volume: 175, Issue:3

    Topics: Adult; Amisulpride; Antipsychotic Agents; Brain; Contrast Media; Dopamine D2 Receptor Antagonists; D

2004
Improvement of amisulpride-induced extrapyramidal symptoms with quetiapine.
    The Australian and New Zealand journal of psychiatry, 2004, Volume: 38, Issue:7

    Topics: Aged; Amisulpride; Antipsychotic Agents; Basal Ganglia Diseases; Dibenzothiazepines; Humans; Male; M

2004
A successful antipsychotic combination trial. Quo Vadis?
    Acta psychiatrica Scandinavica, 2004, Volume: 110, Issue:4

    Topics: Amisulpride; Antipsychotic Agents; Clozapine; Drug Synergism; Drug Therapy, Combination; Humans; Psy

2004
Tardive dyskinesia after long-term veralipride treatment.
    The Journal of neuropsychiatry and clinical neurosciences, 2005,Spring, Volume: 17, Issue:2

    Topics: Aged; Aged, 80 and over; Dyskinesia, Drug-Induced; Female; Humans; Psychotic Disorders; Sulpiride

2005
Atypical anti-psychotics in the real world--a naturalistic comparative outcome study.
    Scottish medical journal, 2005, Volume: 50, Issue:3

    Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiaz

2005
[Amisulpride in Huntington's disease].
    Psychiatrische Praxis, 2005, Volume: 32, Issue:7

    Topics: Aged; Amisulpride; Antipsychotic Agents; Delusions; Dose-Response Relationship, Drug; Drug Administr

2005
Amisulpride-induced hyperprolactinemia is reversible following discontinuation.
    Progress in neuro-psychopharmacology & biological psychiatry, 2007, Jan-30, Volume: 31, Issue:1

    Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Humans; Hy

2007
The use of atypical antipsychotics in French psychiatric hospitals.
    Pharmacy world & science : PWS, 2007, Volume: 29, Issue:5

    Topics: Adult; Age Factors; Amisulpride; Antimanic Agents; Antiparkinson Agents; Antipsychotic Agents; Benzo

2007
Is aripiprazole the only choice of treatment of the patients who developed anti-psychotic agents-induced leucopenia and neutropenia? A case report.
    Journal of psychopharmacology (Oxford, England), 2008, Volume: 22, Issue:3

    Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Blood Cell Count; Dibenzothiazepines; Female

2008
[Sulpiride (Dogmatil). A new antipsychosis agent (neuroleptic) with few side effects].
    Ugeskrift for laeger, 1983, Aug-22, Volume: 145, Issue:34

    Topics: Antipsychotic Agents; Humans; Psychotic Disorders; Sulpiride

1983
[Long-term dogmatil therapy in major psychiatry].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1983, May-12, Volume: 59, Issue:19

    Topics: Adult; Delusions; Female; Follow-Up Studies; Humans; Inhibition, Psychological; Male; Mental Disorde

1983
Effects of chronic sultopride treatment on endocrine systems in psychotic women.
    Psychopharmacology, 1984, Volume: 82, Issue:4

    Topics: Adult; Amisulpride; Chronic Disease; Estradiol; Female; Follicle Stimulating Hormone; Growth Hormone

1984
Weight gain: side effect of atypical neuroleptics?
    Journal of clinical psychopharmacology, 1999, Volume: 19, Issue:4

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Body Mass Index; C

1999
[Acute tongue and pharyngeal spasms during changeover from clozapine to amisulpride. A case example].
    Der Nervenarzt, 2000, Volume: 71, Issue:11

    Topics: Acute Disease; Adult; Amisulpride; Antipsychotic Agents; Clozapine; Drug Administration Schedule; Dr

2000
[Initial experiences with amisulpride, an in Germany novel, atypical neuroleptic drug in treatment of adolescents with psychiatric disorders].
    Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie, 2001, Volume: 29, Issue:3

    Topics: Adolescent; Amisulpride; Antipsychotic Agents; Child; Dose-Response Relationship, Drug; Drug Adminis

2001
[Substituted benzamides].
    L'Encephale, 1975, Volume: 1, Issue:3

    Topics: Antipsychotic Agents; Benzamides; Humans; Psychotic Disorders; Sulpiride

1975
Effect of sulpiride on monoaminergic mechanisms in psychotic women.
    Psychopharmacology, 1979, Aug-08, Volume: 64, Issue:2

    Topics: Adult; Aged; Biogenic Amines; Female; Humans; Middle Aged; Prolactin; Psychotic Disorders; Sulpiride

1979
[Trial therapy of psychomotor disorder with a new neuroleptic, sultopride].
    Bruxelles medical, 1979, Volume: 59, Issue:5

    Topics: Aged; Benzamides; Drug Evaluation; Humans; Male; Middle Aged; Psychotic Disorders; Sulpiride

1979
[Sultopride in a day hospital].
    Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille, 1979, Nov-17, Volume: Suppl 1

    Topics: Amisulpride; Bipolar Disorder; Day Care, Medical; Hospitals, Psychiatric; Humans; Male; Mental Disor

1979
On the relevance of preferential increases of mesolimbic versus striatal dopamine turnover for the prediction of antipsychotic activity of psychotropic drugs.
    Journal of neurochemistry, 1976, Volume: 27, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anthracenes; Clozapine; Corpus Striatum; Dopamine; Dose-Res

1976
[Sulpiride and psychic decompensation].
    L'Encephale, 1976, Volume: 2, Issue:4

    Topics: Anxiety; Autistic Disorder; Cognition Disorders; Depression; Humans; Psychotic Disorders; Sulpiride

1976
Therapeutic spectrum of sulpiride, haloperidol and lithium: a graphic representation by clinical observation.
    Osaka city medical journal, 1976, Volume: 22, Issue:1

    Topics: Haloperidol; Humans; Lithium; Models, Theoretical; Psychotic Disorders; Sulpiride

1976
Veralipride-induced tardive dystonia in a patient with bipolar psychosis.
    Italian journal of neurological sciences, 1992, Volume: 13, Issue:7

    Topics: Dystonia; Female; Humans; Menopause; Middle Aged; Psychotic Disorders; Sulpiride

1992
Our experience with incisive neuroleptic drugs in child psychiatry.
    Acta Universitatis Palackianae Olomucensis Facultatis Medicae, 1991, Volume: 131

    Topics: Antipsychotic Agents; Autistic Disorder; Child; Haloperidol; Humans; Mental Disorders; Obsessive-Com

1991
Sulpiride-induced tardive dystonia.
    Movement disorders : official journal of the Movement Disorder Society, 1990, Volume: 5, Issue:1

    Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Dystonia; Humans; Male; Psychotic Disorders;

1990
[Eglonyl in the treatment of schizoaffective psychoses].
    Ceskoslovenska psychiatrie, 1990, Volume: 86, Issue:4

    Topics: Adult; Female; Humans; Middle Aged; Psychotic Disorders; Sulpiride

1990
[The role of a mediator object in the initial analytic therapy of psychotics].
    Annales medico-psychologiques, 1986, Volume: 144, Issue:6

    Topics: Amisulpride; Antipsychotic Agents; Combined Modality Therapy; Humans; Psychoanalytic Therapy; Psycho

1986
Early clinical experiences with sulpiride.
    The British journal of psychiatry : the journal of mental science, 1985, Volume: 146

    Topics: Female; Humans; Male; Psychotic Disorders; Sulpiride

1985
[Few comments on sulpiride].
    Semaine des hopitaux. Therapeutique, 1974, Volume: 50, Issue:3

    Topics: Humans; Psychotic Disorders; Sulpiride

1974
A clinical experiment with sulpiride.
    The Israel annals of psychiatry and related disciplines, 1973, Volume: 11, Issue:2

    Topics: Adolescent; Adult; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Psychotic Disorde

1973
[Sulpiride: a new psychotropic compound].
    Harefuah, 1974, Jun-02, Volume: 86, Issue:11

    Topics: Humans; Psychotic Disorders; Schizophrenia; Sulpiride

1974